CXCR4 and breast carcinoma: Over expression of the inhibitor of NF-κB (IκB) in breast cancer cells constitutively expressing NF-κB results in reduced expression of CXCR4 and a corresponding loss of SDF-1α-mediated migration in vitro [26].